Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents. 2016

P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
Fluoroorganic Division, Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India.

A series of novel pyrazolo[3,4-b]pyridine based target compounds were synthesized starting from the key intermediate ethyl 2-(3-amino-6-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetate 5 on reaction with hydrazine hydrate followed by reaction with different aldehydes, acid chlorides and isothiocyanates to form hydrazones 7, oxadiazoles 8, 1,2,4 triazoles 10 and thiadiazoles 11 respectively in high yield. All the final compounds were screened for anticancer activity against four human cancer cell lines. Among them, 1,2,4 triazole derivatives showed promising activity and compound 10d is identified as a lead molecule.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
November 2013, Bioorganic & medicinal chemistry letters,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
August 2016, Bioorganic chemistry,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
November 2009, European journal of medicinal chemistry,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
September 2021, Bioorganic & medicinal chemistry letters,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
January 2016, Biological & pharmaceutical bulletin,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
January 2012, Organic & biomolecular chemistry,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
July 2017, European journal of medicinal chemistry,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
January 2023, RSC medicinal chemistry,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
August 2007, Bioorganic & medicinal chemistry letters,
P Nagender, and R Naresh Kumar, and G Malla Reddy, and D Krishna Swaroop, and Y Poornachandra, and C Ganesh Kumar, and B Narsaiah
February 2014, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!